Patients with langerhans cell histiocytosis and hypothalamic-pituitary involvement: insights from the HEROS study cohort
Patients with LCH and hypothalamic-pituitary involvement remained clinically stable during long-term follow-up. However, new hormonal deficits may develop years after diagnosis, with most patients ultimately experiencing AVD.
Authors
- Miklós Tóth (ORCID: https://orcid.org/0000-0002-8701-408X)
- Hiba Masri Iraqi
- Yona Greenman (ORCID: https://orcid.org/0000-0003-4923-488X)
- Gregory Kaltsas (ORCID: https://orcid.org/0000-0002-5876-7883)
- Ekaterina Pigarova (ORCID: https://orcid.org/0000-0001-6539-466X)
- Diego Ferone (ORCID: https://orcid.org/0000-0002-1410-6143)
- Lior Baraf (ORCID: https://orcid.org/0000-0001-8714-1858)
- Marina Tsoli (ORCID: https://orcid.org/0000-0002-6013-5893)
- Amit Akirov (ORCID: https://orcid.org/0000-0002-9376-344X)
- Ilan Shimon (ORCID: https://orcid.org/0000-0002-9188-3894)
- Annamaria Colao (ORCID: https://orcid.org/0000-0003-4049-2559)
- Mirjana Doknić (ORCID: https://orcid.org/0000-0003-2701-4800)
Institutions
- Semmelweis University (HU)
- University of Padua (IT)
- Tel Aviv University (IL)
- Tel Aviv Sourasky Medical Center (IL)
- Rabin Medical Center (IL)
- Soroka Medical Center (IL)
- University of Belgrade (RS)
- Endocrinology Research Center (RU)
- Laiko General Hospital of Athens (GR)
- Ospedale Policlinico San Martino (IT)
- University of Naples Federico II (IT)
Publication Details
- Journal
- Pituitary
- Published
- 2025-09-26
- DOI
- https://doi.org/10.1007/s11102-025-01576-3
- Primary Topic
- Histiocytic Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00